Close Menu

NEW YORK – Two Medicare Administrative Contractors released draft local coverage determinations last week denying a request from Myriad Genetic Laboratories to expand coverage of its EndoPredict breast cancer gene expression test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.